CN Patent

CN1993338B — 二芳基甲基哌嗪衍生物及其制备方法和用途

Assigned to AstraZeneca AB · Expires 2011-07-06 · 15y expired

What this patent protects

制备下列式的化合物，和其盐，对映异构体，以及包含该化合物的药物组合物。它们用于治疗，尤其用于治疗疼痛，抑郁和焦虑。

USPTO Abstract

制备下列式的化合物，和其盐，对映异构体，以及包含该化合物的药物组合物。它们用于治疗，尤其用于治疗疼痛，抑郁和焦虑。

Drugs covered by this patent

pitolisant-hydrochloride (PITOLISANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN1993338B
Jurisdiction: CN
Classification: —
Expires: 2011-07-06
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.